APA (7th ed.) Citation

Seidling, V., Hoffmann, J., Enk, A., & Hadaschik, E. (2013). Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: High efficacy and no serious adverse events. Acta dermato-venereologica, 93(3), . https://doi.org/10.2340/00015555-1471

Chicago Style (17th ed.) Citation

Seidling, Vera, Jochen Hoffmann, Alexander Enk, and Eva Hadaschik. "Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events." Acta Dermato-venereologica 93, no. 3 (2013). https://doi.org/10.2340/00015555-1471.

MLA (9th ed.) Citation

Seidling, Vera, et al. "Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events." Acta Dermato-venereologica, vol. 93, no. 3, 2013, https://doi.org/10.2340/00015555-1471.